Pfizer | PFE - Dochód Netto

Cena Akcji
26.26
Dzienna Zmiana
-0.22 -0.83%
Miesięcznie
-5.44%
Rocznie
7.58%
Q2 Prognozy TE
26.42




Dochód Netto Zmiana Data
AbbVie USD 695M 1.12B 2026-03
Abbott USD 1.08B 699M 2026-03
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merck USD 2.96B 2.82B 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Sanofi EUR -801M 3.6B 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Zoetis USD 603M 118M 2025-12